MoonLake Immunotherapeutics ($MLTX)
Filing Information
| Accession Number | 0001213900-26-069753 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
150,000
Total Value
$2,851,000.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jun 15, 2026 | Sale | 50,000 | $18.89 | $944,500.00 | 2,924,551 | Indirect | See footnote. | View Details | |
Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jun 16, 2026 | Sale | 50,000 | $18.70 | $935,000.00 | 2,874,551 | Indirect | See footnote. | View Details | |
Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jun 17, 2026 | Sale | 50,000 | $19.43 | $971,500.00 | 2,824,551 | Indirect | See footnote. | View Details |